The recent HAS symposium, Together for HTA in Europe, reviewed the unique opportunity that EU HTA Regulation presents for patients and health care systems across the EU, with the potential for more timely and broader access to innovative medicines.

The implementation of the HTA Regulation towards a workable system is a shared responsibility of multiple stakeholders to ensure that it is more than the sum of the currently fragmented national work with all its shortcomings. Involvement of the following stakeholders to address the key areas for implementation, as identified by the EFPIA, will be core to success: EC, Member States, HTA agencies and stakeholders, including patient representatives and industry.

EFPIA article: How can we make the joint EU HTA more than just a sum of the currently fragmented national work (Guest blog)